Prescribed By :General Physician, Pulmonologist, ENT Specialist
Product Description
Key Benefits of CF SR
Broad cover across gram-positive, gram-negative, atypical and anaerobic organisms
Once-daily dosing
Useful in respiratory infections where mixed organisms are suspected
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of CF SR
Community-acquired pneumonia
Acute bacterial sinusitis
Acute exacerbation of chronic bronchitis
Skin and soft tissue infections
How CF SR works
Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV. Its structure widens the spectrum to include gram-positive, atypical and several anaerobic organisms alongside gram-negative cover, which makes it useful where a mixed infection is likely.
Why ChooseCF SR?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about CF SR
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of CF SR?
Moxifloxacin 400mg SR + Cefixime 400mg.
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.
Cista Medicorp
